2023-11-15 | VYNE Therapeutics Inc. VYNE | director | 13,000 0.3748% | $3.91 | $50,778 | -44.13% | ||
2021-11-30 | VYNE Therapeutics Inc. VYNE | director | 12,500 0.024% | $1.02 | $12,699 | -55.58% | ||
2021-08-25 | VYNE Therapeutics Inc. VYNE | director | 12,500 0.0243% | $1.60 | $20,000 | -62.28% | ||
2021-05-26 | VYNE Therapeutics Inc. VYNE | director | 12,500 0.0241% | $3.60 | $44,958 | -68.32% | ||
2021-03-15 | VYNE Therapeutics Inc. VYNE | director | 12,500 0.0259% | $7.41 | $92,563 | -79.34% | ||
2020-12-03 | VYNE Therapeutics Inc. VYNE | director | 100,000 0.078% | $1.71 | $170,850 | -46.15% | ||
2020-05-14 | Matinas BioPharma Holdings, Inc. MTNB | director | 100,000 0.0504% | $0.73 | $73,050 | |||
2019-11-15 | Matinas BioPharma Holdings, Inc. MTNB | director | 200,000 0.0623% | $0.53 | $105,530 | |||
2019-08-16 | Matinas BioPharma Holdings, Inc. MTNB | director | 200,000 0.1309% | $0.72 | $143,700 | |||
2019-05-16 | Matinas BioPharma Holdings, Inc. MTNB | director | 200,000 0.1423% | $0.95 | $190,500 |